Transparency and Disclosure Agreement -ProEMR

Transparency and Disclosure Agreement

 

This Complete EHR is 2014 Edition compliant and has been certified by ICSA Labs in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

 

  1. The vendor name – MD Synergy Solutions LLC.
  2. The date certified – March 2014
  3. The product name and version – ProEMR Version-3.0
  4. CHPL Certification ID- CC-2014-697871-1

 

  1. Certified Criteria

 

 

Criterion # and Description

 

Met/Exempt

 

§ 170.314(a)(1) Computerized Provider Order Entry

 

Pass

 

§ 170.314(a)(2) Drug-Drug, Drug-Allergy Interaction Checks

 

Pass

 

§ 170.314(a)(3) Demographics

 

Pass

 

§ 170.314(a)(4) Vital Signs, Body Mass Index, and Growth Charts

 

Pass

 

§ 170.314(a)(5) Problem List

 

Pass

 

§ 170.314(a)(6) Medication List

 

Pass

 

§ 170.314(a)(7) Medication Allergy List

 

Pass

 

§ 170.314(a)(8) Clinical Decision Support

 

Pass

 

§ 170.314(a)(9) Electronic Notes

 

Pass

 

§ 170.314(a)(10) Drug Formulary Checks

 

Pass

 

§ 170.314(a)(11) Smoking Status

 

Pass

 

§ 170.314(a)(12) Image Results

 

Pass

 

§ 170.314(a)(13) Family Health History

 

Pass

 

§ 170.314(a)(14) Patient List Creation

 

Pass

 

§ 170.314(a)(15) Patient-Specific Education Resources

 

Pass

 

§ 170.314(b)(1) Transitions of Care – Receive, Display, and Incorporate

Transition

 

Pass

 

§ 170.314(b)(2) Transitions of Care – Create and Transmit Summary Care

 

Pass

 

§ 170.314(b)(3) Electronic Prescribing

 

Pass

 

§ 170.314(b)(4) Clinical Information Reconciliation

 

Pass

 

 

 

 

Criterion # and Description

 

Met/Exempt

 

§ 170.314(b)(5) Incorporate Laboratory Tests and Values/Results

 

Pass

 

§ 170.314(b)(7) Data Portability

 

Pass

 

§ 170.314(c)(1) Clinical Quality Measures – Capture and Export

 

Pass

 

§ 170.314(c)(2) Clinical Quality Measures – Incorporate and Calculate

 

Pass

 

§ 170.314(c)(3) Clinical Quality Measures – Electronic Submission

Pass
 

§ 170.314(d)(1) Authentication, Access Control, and Authorization

Pass
 

§ 170.314(d)(2) Auditable Events and Tamper-Resistance

Pass
 

§ 170.314(d)(3) Audit Report(s)

Pass
 

§ 170.314(d)(4) Amendments

Pass
 

§ 170.314(d)(5) Automatic Log-Off

Pass
 

§ 170.314(d)(6) Emergency Access

Pass
 

§ 170.314(d)(7) End-User Device Encryption

Pass
 

§ 170.314(d)(8) Integrity

Pass
 

§ 170.314(d)(9) Optional – Accounting of Disclosures

N/A
 

§ 170.314(e)(1) View, Download, and Transmit to 3rd Party

Pass
 

§ 170.314(e)(2) Clinical Summary – Ambulatory Setting Only

Pass
 

§ 170.314(e)(3) Secure Messaging – Ambulatory Setting Only

Pass
 

§ 170.314(f)(1) Immunization Information

Pass
 

§ 170.314(f)(2) Transmission to Immunization Registries

Pass
 

§ 170.314(f)(3) Transmission to Public Health Agencies – Syndromic

Surveillance

Pass
 

§ 170.314(f)(5) Cancer Case Information – Ambulatory Setting Only

N/A
 

§ 170.314(f)(6) Transmission to Cancer Registries – Ambulatory Setting Only

N/A
 

§ 170.314(g)(1) Automated Numerator Recording

N/A
 

§ 170.314(g)(2) Automated Measure Calculation

Pass
 

§ 170.314(g)(3) Safety-Enhanced Design

Pass
 

§ 170.314(g)(4) Quality Management System

Pass

 

 

 

 

 

 

 

 

  1. Certified Clinical Quality Measures

 

  • CMS69 – PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
  • CMS129 – PROSTRATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK CANCER PATIENTS
  • CMS138 – PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION CMS139 – SCREENING FOR FUTURE FALL RISK
  • CMS146 – APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
  • CMS154 – APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
  • CMS155 – WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
  • CMS165 – CONTROLLING HIGH BLOOD PRESSURE
  • CMS166 – USE OF IMAGING STUDIES FOR LOW BACK PAIN

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  1. Additional Software

 

Self-attested Additional Software Used in Testing:

 

Product Name

 

Product Version

 

Supplier

 

Criteria this product supports

 

MedKnowledge

 

October 2013

 

First Databank Drug

Database

 

§ 170.314(a)(1)

§ 170.314(a)(2)

§ 170.314(a)(6)

§ 170.314(a)(7)

§ 170.314(a)(10)

§ 170.314(b)(1)

§ 170.314(b)(2)

§ 170.314(b)(3)

§ 170.314(b)(7)

§ 170.314(c)(1)

§ 170.314(e)(1)

§ 170.314(e)(2)

 

Medline Plus

 

NA

 

National Institute of

Health

§ 170.314(a)(8)

§ 170.314(a)(15)

 

Problem (IT) Terminology

 

2014 R1.1

 

Intelligent Medical

Objects

§ 170.314(a)(1)

§ 170.314(a)(5)

§ 170.314(a)(8)

§ 170.314(a)(11)

§ 170.314(a)(13)

§ 170.314(a)(15)

§ 170.314(b)(1)

§ 170.314(b)(2)

§ 170.314(b)(5)

§ 170.314(b)(7)

§ 170.314(c)(1)

§ 170.314(e)(1)

§ 170.314(e)(2)

 

Procedure (IT) Terminology

 

2014 Procedure IT FULL

 

Intelligent Medical

Objects

 

§ 170.314(a)(1)

§ 170.314(a)(8)

§ 170.314(a)(15)

§ 170.314(b)(1)

§ 170.314(b)(2)

§ 170.314(b)(5)

§ 170.314(b)(7)

§ 170.314(c)(1)

§ 170.314(e)(1)

§ 170.314(e)(2)

 

 

 

  1. Disclosure of Additional types of costs where applicable

None.

 

  1. Disclosure of any limitations where applicable

There are no known limitations that a user may encounter in the course of implementing and using this Complete EHR’s capabilities, whether to meet meaningful use objectives and measures or to achieve any other use within the scope of the health IT’s certification.